These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 6781025

  • 1. [Principles and concepts of teratogenesis. I. The teratogenic injury (author's transl)].
    Rooze M.
    Rev Med Brux; 1980 Oct; 1(8):523-33. PubMed ID: 6781025
    [No Abstract] [Full Text] [Related]

  • 2. [Lithium and pregnancy (author's transl)].
    Mignot G, Devic M, Dumont M.
    J Gynecol Obstet Biol Reprod (Paris); 1978 Oct; 7(7):1303-17. PubMed ID: 106083
    [Abstract] [Full Text] [Related]

  • 3. [Drugs, environment and teratogenesis].
    Mariani L.
    Clin Ter; 1976 Apr 15; 77(1):3-19. PubMed ID: 827412
    [No Abstract] [Full Text] [Related]

  • 4. Drugs of abuse: teratogenic and mutagenic considerations.
    Evans MA, Stevens MW, Mantilla-Plata B, Harbison RD.
    Addict Dis; 1975 Apr 15; 2(1-2):45-61. PubMed ID: 1163373
    [No Abstract] [Full Text] [Related]

  • 5. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F, Rohatagi S, Pino M, DeLise B, Zhang J, Nguyen M, Guittin P, Barbellion S, Brunel P, Hofmann T, Schmidt J, Wong M, Lockey P, Lerman S, Clark R.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr 15; 71(2):69-79. PubMed ID: 15098200
    [Abstract] [Full Text] [Related]

  • 6. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F, Pino M, DeLise B, Guittin P, Barbellion S, Brunel P, Potdevin S, Bergmann B, Hofmann T, Lerman S, Clark RL.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr 15; 71(2):55-68. PubMed ID: 15098199
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of known environmental teratogens: drugs and chemicals.
    Beckman DA, Brent RL.
    Clin Perinatol; 1986 Sep 15; 13(3):649-87. PubMed ID: 3533369
    [Abstract] [Full Text] [Related]

  • 8. [Embryotoxic properties of drugs].
    Smol'nikova NM, Golovanova IV, Proĭnova VA, Skosyreva AM, Strekalova SN.
    Farmakol Toksikol; 1982 Sep 15; 45(4):115-9. PubMed ID: 6751867
    [No Abstract] [Full Text] [Related]

  • 9. [The teratogenic action of parbendazole].
    Mercier-Parot L.
    Therapie; 1976 Sep 15; 31(4):491-503. PubMed ID: 1036798
    [No Abstract] [Full Text] [Related]

  • 10. Teratogenicity of sodium arsenate in rats.
    Beaudoin AR.
    Teratology; 1974 Oct 15; 10(2):153-7. PubMed ID: 4428424
    [No Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetics].
    Cahen R.
    Eur J Toxicol Hyg Environ; 1972 Oct 15; Suppl 3():67-80. PubMed ID: 4157455
    [No Abstract] [Full Text] [Related]

  • 12. [Editorial: Teratogenic agents].
    Ferrier PE.
    Helv Paediatr Acta; 1975 May 15; 30(1):5-9. PubMed ID: 1158766
    [No Abstract] [Full Text] [Related]

  • 13. [The basic methodological approaches to testing the teratogenic activity of chemical substances].
    Dyban AP, Baranov VS, Akimova IM.
    Arkh Anat Gistol Embriol; 1970 May 15; 59(10):89-100. PubMed ID: 5511190
    [No Abstract] [Full Text] [Related]

  • 14. [Pharmacotherapy during pregnancy. Teratological aspects (author's transl)].
    Held KR.
    MMW Munch Med Wochenschr; 1981 Aug 07; 123(32-33):1235-8. PubMed ID: 6790971
    [Abstract] [Full Text] [Related]

  • 15. A TERATOGENIC EFFECT OF A SULPHONAMIDE IN EXPERIMENTAL ANIMALS.
    PAGET GE, THORPE E.
    Br J Pharmacol Chemother; 1964 Oct 07; 23(2):305-12. PubMed ID: 14228132
    [Abstract] [Full Text] [Related]

  • 16. Is fluphenazine a teratogen?
    Merlob P, Stahl B, Maltz E.
    Am J Med Genet; 1994 Aug 15; 52(2):231-2. PubMed ID: 7802015
    [No Abstract] [Full Text] [Related]

  • 17. Corticosteroid teratogenicity.
    Rowland JM, Hendrickx AG.
    Adv Vet Sci Comp Med; 1983 Aug 15; 27():99-128. PubMed ID: 6359839
    [No Abstract] [Full Text] [Related]

  • 18. [The superior celosomia (author's transl)].
    Gaillard D, Morville P, Birembaut P, Mourad H, Quereux C, Leroux B, Daoud S.
    Ann Pediatr (Paris); 1981 Jan 15; 28(1):51-4. PubMed ID: 7235530
    [No Abstract] [Full Text] [Related]

  • 19. Problems associated with the screening of drugs for possible teratogenic activity.
    Palmer AK.
    Exp Embryol Teratol; 1974 Jan 15; 1(0):16-33. PubMed ID: 4464051
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC, Jacobson CF, Gao F, Tassinari MS, Hurtt ME, DeSesso JM.
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb 15; 68(1):5-26. PubMed ID: 12852480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.